Health Care [ 5/12 ] | Biotechnology [ 25/74 ]
NASDAQ | Common Stock
Ikena Oncology, Inc., an oncology company, focuses on developing therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance.
It develops IK-595, a molecular glue designed to trap MEK and RAF in an inactive complex.
The company was incorporated in 2016 and is headquartered in Boston, Massachusetts.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Mar 10, 25 | -0.18 Increased by +61.28% | -0.17 Decreased by -7.06% |
| Nov 7, 24 | -0.21 Increased by +47.50% | -0.27 Increased by +22.22% |
| Aug 8, 24 | -0.28 Increased by +36.36% | -0.35 Increased by +20.00% |
| May 13, 24 | -0.33 Increased by +15.38% | -0.41 Increased by +19.51% |
| Mar 12, 24 | -0.47 Decreased by -17.50% | -0.43 Decreased by -9.30% |
| Nov 9, 23 | -0.40 Increased by +16.67% | -0.43 Increased by +6.98% |
| Aug 10, 23 | -0.44 Increased by +22.81% | -0.47 Increased by +6.38% |
| May 15, 23 | -0.39 Increased by +17.02% | -0.47 Increased by +17.02% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 24 | 0.00 Decreased by -100.00% | -9.12 M Increased by +53.18% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 24 | 0.00 Decreased by -100.00% | -10.23 M Increased by +40.99% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by -100.00% | -13.73 M Increased by +19.78% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by -100.00% | -16.15 M Decreased by -13.55% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 23 | 659.00 K Decreased by -87.91% | -19.49 M Decreased by -49.00% | Decreased by -2.96 K% Decreased by -1.13 K% |
| Sep 30, 23 | 1.19 M Decreased by -81.49% | -17.34 M Decreased by -3.23% | Decreased by -1.46 K% Decreased by -457.71% |
| Jun 30, 23 | 2.00 M Increased by +424.61% | -17.11 M Increased by +14.56% | Decreased by -854.04% Increased by +83.71% |
| Mar 31, 23 | 5.31 M Increased by +57.00% | -14.22 M Increased by +14.94% | Decreased by -267.63% Increased by +45.82% |